Keep Reading
- What’s the biggest challenge facing the cannabis industry right now, and how are you and/or your company addressing it?
On a broader level, the tax burdens associated with 280E are hurting all operators. In the states we operate in, we are currently working through price compression, increased competition, delays with AR, and the constant moving targets that exist. I love it though. Challenges are opportunities, and that’s how we approach everything we do at Silver Therapeutics.
Read the rest of the five questions on beardbrospharms.com!
Article Written by
